ISSUER PROFILE · CIK 0001631574
Wave Life Sciences, Inc.WVE
10 13D/G filings
3 distinct filers
21 insider transactions (365d)
Cross-Reference Snapshot
Activist filings
10
1 SCHEDULE 13D/A · 9 SC
Distinct filers
3
multi-activist cluster
Insiders (365d)
21
16 buys · 4 sales
Latest short DTC
6.53
as of 2026-10-15
Institutional Consensus · 2026-06-30
Held by elite portfolio managers
1 holder · $1K
Duquesne Family Office
13D/G Filings Timeline · 10 total
| Filed | Form | Filer | Stake | Shares | Intent | |
|---|
| 2026-08-11 |
SCHEDULE 13D/A |
RA CAPITAL MANAGEMENT, L.P. |
— |
34,314,406 |
|
view → |
| 2024-10-01 |
SC |
RA CAPITAL MANAGEMENT, L.P. |
— |
— |
|
view → |
| 2022-08-12 |
SC |
Shin Nippon Biomedical Laboratories, Ltd. |
— |
— |
|
view → |
| 2022-07-20 |
SC |
Kagoshima Shinsangyo Sousei Investment Limited Partnership |
— |
— |
|
view → |
| 2021-11-12 |
SC |
RA CAPITAL MANAGEMENT, L.P. |
— |
— |
|
view → |
| 2021-08-18 |
SC |
RA CAPITAL MANAGEMENT, L.P. |
— |
— |
|
view → |
| 2019-02-20 |
SC |
Shin Nippon Biomedical Laboratories, Ltd. |
— |
— |
|
view → |
| 2019-01-28 |
SC |
RA CAPITAL MANAGEMENT, LLC |
— |
— |
|
view → |
| 2018-04-26 |
SC |
Shin Nippon Biomedical Laboratories, Ltd. |
— |
— |
|
view → |
| 2018-03-22 |
SC |
Kagoshima Shinsangyo Sousei Investment Limited Partnership |
— |
— |
|
view → |
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-10-05 |
RA CAPITAL MANAGEMENT, L.P. |
director, 10%+ |
Award |
10,700 |
— |
— |
| 2026-10-05 |
RA CAPITAL MANAGEMENT, L.P. |
director, 10%+ |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
Verdine Gregory L. |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
Verdine Gregory L. |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
Tan Aik Na |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
Tan Aik Na |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
TAKANASHI KEN |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
TAKANASHI KEN |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
CORRIGAN MARK |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
CORRIGAN MARK |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
Rawcliffe Adrian |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
Rawcliffe Adrian |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
Wagner Heidi L |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
Wagner Heidi L |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-10-05 |
HENRY CHRISTIAN O |
director |
Award |
10,700 |
— |
— |
| 2026-10-05 |
HENRY CHRISTIAN O |
director |
Award |
64,000 |
$3.75 |
$240K |
| 2026-08-12 |
Rawcliffe Adrian |
director |
Sale |
12,700 |
$5.29 |
$67K |
| 2026-08-11 |
Wagner Heidi L |
director |
Option exercise |
7,000 |
$5.97 |
$42K |
| 2026-08-11 |
Wagner Heidi L |
director |
Sale |
7,000 |
$6.01 |
$42K |
| 2026-08-11 |
TAKANASHI KEN |
director |
Sale |
3,864 |
$6.01 |
$23K |
| 2026-08-11 |
Tan Aik Na |
director |
Sale |
432 |
$6.01 |
$3K |
FINRA Short Interest History
| Settlement | Short Interest | Days to Cover | % Δ vs prior |
|---|
| 2026-10-15 |
21,167,722 |
6.53 |
+14.1% |
| 2026-09-30 |
18,556,315 |
5.70 |
+5.2% |
| 2026-09-15 |
17,637,783 |
5.17 |
+8.3% |
| 2026-08-14 |
16,200,874 |
4.39 |
-1.2% |
| 2026-07-31 |
16,401,737 |
7.45 |
-2.6% |
| 2026-07-15 |
16,848,760 |
6.30 |
-19.4% |
| 2026-06-30 |
20,901,285 |
5.68 |
+15.1% |
| 2026-06-15 |
18,153,025 |
5.58 |
-2.0% |
| 2026-05-29 |
18,530,652 |
4.57 |
+4.3% |
| 2026-05-15 |
17,770,733 |
4.15 |
+6.3% |
| 2026-04-30 |
16,720,976 |
4.14 |
+25.3% |
| 2026-04-15 |
13,345,828 |
3.94 |
+1.0% |
Alert me when any activist files on Wave Life Sciences, Inc.
Free. We email you when criteria match. One-click unsubscribe in every email.
Track every activist who touches this name.
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →